INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Public company

JAZZJazz Pharmaceuticals plc

CIK 0001232524

EDGAR filingsOpen in network
Disclosed transactions49
Buys / sells0 / 15
Max Insider Score36
Connections14with evidence

JAZZ · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
11
GD
Gala Renee DDirector, President & CEO
JAZZJazz Pharmaceuticals plc
Open-market sale · 10b5-1 plan
SELL$473K
2,000 sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Connected organizationevidence
    JAZZ PHARMACEUTICALS, INC. POLITICAL ACTION COMMITTEEFEC Form 1 connected organization: JAZZ PHARMACEUTICALS, INC. (exact legal-name match) · Nov 4, 2026
  • ← Insider ofevidence
    Gala Renee DDirector, President & CEO · Oct 7, 2026
  • ← Insider ofevidence
    Iannone RobertEVP, Global Head of R&D & CMO · Aug 31, 2026
16
PM
Patil Neena MEVP & Chief Legal Officer
JAZZJazz Pharmaceuticals plc
Open-market sale · 10b5-1 plan
SELL
$289K
1,200 sh
Sep 10, 2026
Sep 14, 2026
traded Sep 10, 2026
+4d
SEC FORM 4

Evidence

5
HE
Henderson Mary ElizabethSVP, Technical Operations
JAZZJazz Pharmaceuticals plc
Tax withholding
F$3,618
15 sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC FORM 4

Evidence

15
HE
Henderson Mary ElizabethSVP, Technical Operations
JAZZJazz Pharmaceuticals plc
Tax withholding
F$343K
1,412 sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC FORM 4

Evidence

15
HE
Henderson Mary ElizabethSVP, Technical Operations
JAZZJazz Pharmaceuticals plc
Tax withholding
F$501K
2,076 sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC FORM 4

Evidence

23
KP
Kennedy PatrickDirector
JAZZJazz Pharmaceuticals plc
Tax withholding
F$444K
1,840 sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC FORM 4

Evidence

9
KP
Kennedy PatrickDirector
JAZZJazz Pharmaceuticals plc
Tax withholding
F$3,661
15 sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC FORM 4

Evidence

5
HE
Henderson Mary ElizabethSVP, Technical Operations
JAZZJazz Pharmaceuticals plc
Tax withholding
F$3,914
16 sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC FORM 4

Evidence

23
IR
Iannone RobertEVP, Global Head of R&D & CMO
JAZZJazz Pharmaceuticals plc
Open-market sale · 10b5-1 plan
SELL$4.53M
18.1K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

23
IR
Iannone RobertEVP, Global Head of R&D & CMO
JAZZJazz Pharmaceuticals plc
Open-market sale · 10b5-1 plan
SELL$2.84M
11.4K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

23
IR
Iannone RobertEVP, Global Head of R&D & CMO
JAZZJazz Pharmaceuticals plc
Open-market sale · 10b5-1 plan
SELL$4.51M
18.2K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

5
IR
Iannone RobertEVP, Global Head of R&D & CMO
JAZZJazz Pharmaceuticals plc
Option exercise · 10b5-1 plan
M$400K
2,916 sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

2
IR
Iannone RobertEVP, Global Head of R&D & CMO
JAZZJazz Pharmaceuticals plc
Option exercise · 10b5-1 plan
M$100K
884 sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

0
IR
Iannone RobertEVP, Global Head of R&D & CMO
JAZZJazz Pharmaceuticals plc
Option exercise · 10b5-1 plan
M—
27.6K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

0
IR
Iannone RobertEVP, Global Head of R&D & CMO
JAZZJazz Pharmaceuticals plc
Option exercise · 10b5-1 plan
M—
26.1K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

0
IR
Iannone RobertEVP, Global Head of R&D & CMO
JAZZJazz Pharmaceuticals plc
Option exercise · 10b5-1 plan
M—
2,916 sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

0
IR
Iannone RobertEVP, Global Head of R&D & CMO
JAZZJazz Pharmaceuticals plc
Option exercise · 10b5-1 plan
M—
884 sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

13
IR
Iannone RobertEVP, Global Head of R&D & CMO
JAZZJazz Pharmaceuticals plc
Open-market sale · 10b5-1 plan
SELL$76K
300 sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

23
IR
Iannone RobertEVP, Global Head of R&D & CMO
JAZZJazz Pharmaceuticals plc
Open-market sale · 10b5-1 plan
SELL$2.33M
9,259 sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

27
IR
Iannone RobertEVP, Global Head of R&D & CMO
JAZZJazz Pharmaceuticals plc
Open-market sale · 10b5-1 plan
SELL$4.92M
19.6K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

16
IR
Iannone RobertEVP, Global Head of R&D & CMO
JAZZJazz Pharmaceuticals plc
Option exercise · 10b5-1 plan
M$2.95M
26.1K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

16
IR
Iannone RobertEVP, Global Head of R&D & CMO
JAZZJazz Pharmaceuticals plc
Option exercise · 10b5-1 plan
M$3.78M
27.6K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

17
KP
Kennedy PatrickDirector
JAZZJazz Pharmaceuticals plc
Grant or award
A—
1,605 sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC FORM 4

Evidence

8
PS
Pearce SamanthaEVP, Chief Commercial Officer
JAZZJazz Pharmaceuticals plc
Tax withholding
F$204K
780 sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC FORM 4

Evidence

19
JL
Johnson Philip LEVP & Chief Financial Officer
JAZZJazz Pharmaceuticals plc
Tax withholding
F$795K
3,343 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC FORM 4

Evidence

19
PS
Pearce SamanthaEVP, Chief Commercial Officer
JAZZJazz Pharmaceuticals plc
Option exercise
M$756K
6,907 sh
May 28, 2026Jun 1, 2026
traded May 28, 2026
+4dSEC FORM 4

Evidence

9
PS
Pearce SamanthaEVP, Chief Commercial Officer
JAZZJazz Pharmaceuticals plc
Option exercise
M—
6,907 sh
May 28, 2026Jun 1, 2026
traded May 28, 2026
+4dSEC FORM 4

Evidence

34
PS
Pearce SamanthaEVP, Chief Commercial Officer
JAZZJazz Pharmaceuticals plc
Open-market sale
SELL$1.63M
6,907 sh
May 28, 2026Jun 1, 2026
traded May 28, 2026
+4dSEC FORM 4

Evidence

15
JL
Johnson Philip LEVP & Chief Financial Officer
JAZZJazz Pharmaceuticals plc
Tax withholding
F$493K
2,615 sh
Mar 5, 2026Mar 9, 2026
traded Mar 5, 2026
+4dSEC FORM 4

Evidence

15
HE
Henderson Mary ElizabethSVP, Technical Operations
JAZZJazz Pharmaceuticals plc
Tax withholding
F$260K
1,394 sh
Mar 5, 2026Mar 9, 2026
traded Mar 5, 2026
+4dSEC FORM 4

Evidence

30
HE
Henderson Mary ElizabethSVP, Technical Operations
JAZZJazz Pharmaceuticals plc
Open-market sale
SELL$1.04M
5,343 sh
Feb 26, 2026Mar 2, 2026
traded Feb 26, 2026
+4dSEC FORM 4

Evidence

17
JL
Johnson Philip LEVP & Chief Financial Officer
JAZZJazz Pharmaceuticals plc
Grant or award
A—
11.9K sh
Feb 26, 2026Mar 2, 2026
traded Feb 26, 2026
+4dSEC FORM 4

Evidence

9
HE
Henderson Mary ElizabethSVP, Technical Operations
JAZZJazz Pharmaceuticals plc
Grant or award
A—
4,447 sh
Feb 26, 2026Mar 2, 2026
traded Feb 26, 2026
+4dSEC FORM 4

Evidence

25
PM
Patil Neena MEVP & Chief Legal Officer
JAZZJazz Pharmaceuticals plc
Disposition to issuer
D$561K
3,275 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC FORM 4

Evidence

23
HE
Henderson Mary ElizabethSVP, Technical Operations
JAZZJazz Pharmaceuticals plc
Grant or award
A—
10.1K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC FORM 4

Evidence

19
PS
Pearce SamanthaEVP, Chief Commercial Officer
JAZZJazz Pharmaceuticals plc
Grant or award
A—
3,637 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC FORM 4

Evidence

21
PS
Pearce SamanthaEVP, Chief Commercial Officer
JAZZJazz Pharmaceuticals plc
Tax withholding
F$274K
1,599 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC FORM 4

Evidence

19
CP
Carr PatriciaSVP, Chief Accounting Officer
JAZZJazz Pharmaceuticals plc
Grant or award
A—
2,370 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC FORM 4

Evidence

19
PM
Patil Neena MEVP & Chief Legal Officer
JAZZJazz Pharmaceuticals plc
Grant or award
A—
8,852 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC FORM 4

Evidence

36
HE
Henderson Mary ElizabethSVP, Technical Operations
JAZZJazz Pharmaceuticals plc
Open-market sale
SELL$379K
2,238 sh
Dec 9, 2025Dec 11, 2025
traded Dec 9, 2025
+2dSEC FORM 4

Evidence

23
CP
Carr PatriciaSVP, Chief Accounting Officer
JAZZJazz Pharmaceuticals plc
Option exercise
M$633K
4,500 sh
Dec 5, 2025Dec 9, 2025
traded Dec 5, 2025
+4dSEC FORM 4

Evidence

22
CP
Carr PatriciaSVP, Chief Accounting Officer
JAZZJazz Pharmaceuticals plc
Open-market sale
SELL$27K
160 sh
Dec 5, 2025Dec 9, 2025
traded Dec 5, 2025
+4dSEC FORM 4

Evidence

36
CP
Carr PatriciaSVP, Chief Accounting Officer
JAZZJazz Pharmaceuticals plc
Open-market sale
SELL$770K
4,500 sh
Dec 5, 2025Dec 9, 2025
traded Dec 5, 2025
+4dSEC FORM 4

Evidence

5
CP
Carr PatriciaSVP, Chief Accounting Officer
JAZZJazz Pharmaceuticals plc
Option exercise
M—
4,500 sh
Dec 5, 2025Dec 9, 2025
traded Dec 5, 2025
+4dSEC FORM 4

Evidence

16
HE
Henderson Mary ElizabethSVP, Technical Operations
JAZZJazz Pharmaceuticals plc
Disposition to issuer
D$240K
1,331 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC FORM 4

Evidence

35
CP
Carr PatriciaSVP, Chief Accounting Officer
JAZZJazz Pharmaceuticals plc
Open-market sale
SELL$956K
5,250 sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC FORM 4

Evidence

27
CP
Carr PatriciaSVP, Chief Accounting Officer
JAZZJazz Pharmaceuticals plc
Option exercise
M$715K
5,250 sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC FORM 4

Evidence

21
CP
Carr PatriciaSVP, Chief Accounting Officer
JAZZJazz Pharmaceuticals plc
Open-market sale
SELL$13K
69 sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC FORM 4

Evidence

9
CP
Carr PatriciaSVP, Chief Accounting Officer
JAZZJazz Pharmaceuticals plc
Option exercise
M—
5,250 sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC FORM 4

Evidence

  • ← Lobbied forevidence
    THE NICKLES GROUP, LLCLDA Q2 2026 second quarter · Medicare/Medicaid, Trade · Aug 26, 2026
  • ← Lobbied forevidence
    TIBER CREEK GROUPLDA Q1 2026 first quarter · Health issues, MED, Budget/appropriations · Aug 26, 2026
  • ← Lobbied forevidence
    TARPLIN, DOWNS & YOUNG, LLCLDA Q1 2026 first quarter · Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    AVENUE SOLUTIONSLDA Q2 2026 second quarter · Health issues, Medicare/Medicaid · Aug 26, 2026
  • ← Insider ofevidence
    Kennedy PatrickDirector · Aug 7, 2026
  • ← Insider ofevidence
    Johnson Philip LEVP & Chief Financial Officer · Mar 2, 2026
  • ← Insider ofevidence
    Pearce SamanthaEVP, Chief Commercial Officer · Jan 21, 2026
  • ← Insider ofevidence
    Patil Neena MEVP & Chief Legal Officer · Jan 21, 2026
  • ← Insider ofevidence
    Henderson Mary ElizabethSVP, Technical Operations · Nov 21, 2025
  • ← Insider ofevidence
    Carr PatriciaSVP, Chief Accounting Officer · Nov 20, 2025

    • Lobbying

    $960K reported · de-duplicated
    2026 Q2 $490K in-house2026 Q1 $470K in-house
    • In-house report$470K2026 Q1 · posted Aug 26, 2026 · Pharmacy
    • TARPLIN, DOWNS & YOUNG, LLC$80K2026 Q2 · posted Aug 26, 2026 · Health issues
    • THE NICKLES GROUP, LLC$50K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid
    • TIBER CREEK GROUP$50K2026 Q2 · posted Aug 26, 2026 · Health issues, MED, Budget/appropriations
    • TARPLIN, DOWNS & YOUNG, LLC$80K2026 Q1 · posted Aug 26, 2026 · Health issues
    • AVENUE SOLUTIONS$50K2026 Q1 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid
    • THE NICKLES GROUP, LLC$50K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid, Trade
    • In-house report$490K2026 Q2 · posted Aug 26, 2026 · Pharmacy
    • TIBER CREEK GROUP$50K2026 Q1 · posted Aug 26, 2026 · Health issues, MED, Budget/appropriations
    • TARPLIN, DOWNS & YOUNG, LLC$80K2026 Q1 · posted Aug 26, 2026 · Health issues
    • AVENUE SOLUTIONS$50K2026 Q2 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid

    Connected PAC contributions

    FEC · direct to members
    • Lateefah SimonD$7,500JAZZ PHARMACEUTICALS, INC. POLITICAL ACTION COMMITTEE
    • Scott H. PetersD$7,500JAZZ PHARMACEUTICALS, INC. POLITICAL ACTION COMMITTEE
    • Roger MarshallR$6,125JAZZ PHARMACEUTICALS, INC. POLITICAL ACTION COMMITTEE
    • John JoyceR$5,000JAZZ PHARMACEUTICALS, INC. POLITICAL ACTION COMMITTEE
    • H. Morgan GriffithR$5,000JAZZ PHARMACEUTICALS, INC. POLITICAL ACTION COMMITTEE
  • Frank Pallone, Jr.D$5,000JAZZ PHARMACEUTICALS, INC. POLITICAL ACTION COMMITTEE
  • John CornynR$3,625JAZZ PHARMACEUTICALS, INC. POLITICAL ACTION COMMITTEE
  • Sam T. LiccardoD$3,500JAZZ PHARMACEUTICALS, INC. POLITICAL ACTION COMMITTEE
  • Donald G. DavisD$2,500JAZZ PHARMACEUTICALS, INC. POLITICAL ACTION COMMITTEE
  • Diana DeGetteD$2,500JAZZ PHARMACEUTICALS, INC. POLITICAL ACTION COMMITTEE
  • Earl L. "Buddy" CarterR$2,500JAZZ PHARMACEUTICALS, INC. POLITICAL ACTION COMMITTEE
  • Gus M. BilirakisR$2,500JAZZ PHARMACEUTICALS, INC. POLITICAL ACTION COMMITTEE
    • Source error

    Price history for JAZZ is unavailable.

    An error occurred in the Server Components render. The specific message is omitted in production builds to avoid leaking sensitive details. A digest property is included on this error instance which may provide additional details about the nature of the error.